Australia markets closed

Suven Pharmaceuticals Limited (SUVENPHAR.BO)

BSE - BSE Real-time price. Currency in INR
Add to watchlist
803.75+18.85 (+2.40%)
At close: 03:29PM IST
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/03/2024
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Assets
Current assets
Cash
Cash and cash equivalents
472,312
648,028
445,638
71,823
-
Other short-term investments
7,775,919
4,189,350
4,812,224
1,805,938
-
Total cash
8,248,231
4,837,378
5,257,862
1,877,761
-
Net receivables
1,336,592
1,109,393
2,363,723
1,023,821
-
Inventory
2,311,957
3,128,104
2,834,173
2,010,804
-
Other current assets
626,931
3
14,563
153
-
Total current assets
12,631,863
10,110,458
11,279,320
5,647,852
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
7,867,760
9,795,745
7,274,015
6,611,143
-
Accumulated depreciation
-
-2,100,975
-1,578,446
-1,262,247
-
Net property, plant and equipment
7,867,760
7,694,770
5,695,569
5,348,896
-
Intangible assets
619,257
19,320
22,364
25,904
-
Other long-term assets
22,371
602,579
-1
-1
-
Total non-current assets
9,909,002
9,546,980
7,016,553
9,096,799
-
Total assets
22,540,865
19,657,438
18,295,873
14,744,651
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
385,753
645,978
671,330
1,056,376
-
Accounts payable
423,574
651,643
1,059,005
829,313
-
Other current liabilities
71,973
21,449
20,992
22,564
-
Total current liabilities
1,068,957
1,587,658
2,102,940
2,197,480
-
Non-current liabilities
Long-term debt
0
45,642
284,404
355,909
-
Deferred tax liabilities
647,912
582,346
543,151
309,329
-
Other long-term liabilities
1
-
-
100
100
Total non-current liabilities
965,273
717,937
921,129
739,188
-
Total liabilities
2,034,230
2,305,595
3,024,069
2,936,668
-
Stockholders' equity
Common stock
254,565
254,565
254,565
254,565
-
Retained earnings
-
14,651,606
12,727,086
9,364,926
6,154,444
Total stockholders' equity
20,506,635
17,351,843
15,271,803
11,808,083
-
Total liabilities and stockholders' equity
22,540,865
19,657,438
18,295,873
14,744,651
-